{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:20:57Z","timestamp":1791253257262,"version":"4.1.0"},"reference-count":191,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-025-03120-9","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T23:39:09Z","timestamp":1746747549000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Leveraging Nanoscience and Strategic Delivery for the Expedition of Osteoporosis"],"prefix":"10.1208","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3482-6837","authenticated-orcid":false,"given":"Pramoda","family":"G","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul K.","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4864-0133","authenticated-orcid":false,"given":"Rahul","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"key":"3120_CR1","doi-asserted-by":"publisher","first-page":"776","DOI":"10.7150\/ijbs.27063","volume":"15","author":"N Su","year":"2019","unstructured":"Su N, Yang J, Xie Y, Du X, Chen H, Zhou H, et al. Bone function, dysfunction and its role in diseases including critical illness. Int J Biol Sci. 2019;15:776\u201387. https:\/\/doi.org\/10.7150\/ijbs.27063.","journal-title":"Int J Biol Sci"},{"key":"3120_CR2","doi-asserted-by":"publisher","first-page":"13361","DOI":"10.1073\/pnas.95.23.13361","volume":"95","author":"GA Rodan","year":"1998","unstructured":"Rodan GA. Bone homeostasis. Proc Natl Acad Sci. 1998;95:13361\u20132. https:\/\/doi.org\/10.1073\/pnas.95.23.13361.","journal-title":"Proc Natl Acad Sci"},{"issue":"289","key":"3120_CR3","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1126\/science.289.5484.1508","volume":"2000","author":"GA Rodan","year":"1979","unstructured":"Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Science. 1979;2000(289):1508\u201314. https:\/\/doi.org\/10.1126\/science.289.5484.1508.","journal-title":"Science"},{"key":"3120_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/IJMM.2021.4915","volume":"47","author":"X Lu","year":"2021","unstructured":"Lu X, Yu S, Chen G, Zheng W, Peng J, Huang X, et al. Insight into the roles of melatonin in bone tissue and bone-related diseases (Review). Int J Mol Med. 2021;47:1\u201319. https:\/\/doi.org\/10.3892\/IJMM.2021.4915.","journal-title":"Int J Mol Med"},{"key":"3120_CR5","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.2147\/TCRM.S138000","volume":"14","author":"F Pouresmaeili","year":"2018","unstructured":"Pouresmaeili F, Kamalidehghan B, Kamarehei M, Goh YM. A comprehensive overview on osteoporosis and its risk factors. Ther Clin Risk Manag. 2018;14:2029\u201349. https:\/\/doi.org\/10.2147\/TCRM.S138000.","journal-title":"Ther Clin Risk Manag"},{"key":"3120_CR6","unstructured":"International Osteoporosis Foundation. Epidemiology of osteoporosis and fragility fractures n.d. https:\/\/www.osteoporosis.foundation\/facts-statistics\/epidemiology-of-osteoporosis-and-fragility-fractures#ref_bottom_1. Accessed March 27, 2025."},{"key":"3120_CR7","doi-asserted-by":"publisher","first-page":"e580","DOI":"10.1016\/S2666-7568(21)00172-0","volume":"2","author":"A-M Wu","year":"2021","unstructured":"Wu A-M, Bisignano C, James SL, Abady GG, Abedi A, Abu-Gharbieh E, et al. Global, regional, and national burden of bone fractures in 204 countries and territories, 1990\u20132019: a systematic analysis from the Global Burden of Disease Study 2019. Lancet Healthy Longev. 2021;2:e580\u201392. https:\/\/doi.org\/10.1016\/S2666-7568(21)00172-0.","journal-title":"Lancet Healthy Longev"},{"key":"3120_CR8","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","volume":"17","author":"O Johnell","year":"2006","unstructured":"Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17:1726\u201333. https:\/\/doi.org\/10.1007\/s00198-006-0172-4.","journal-title":"Osteoporos Int"},{"key":"3120_CR9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/PL00004148","volume":"7","author":"B Gullberg","year":"1997","unstructured":"Gullberg B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporos Int. 1997;7:407\u201313. https:\/\/doi.org\/10.1007\/PL00004148.","journal-title":"Osteoporos Int"},{"key":"3120_CR10","doi-asserted-by":"publisher","first-page":"8182","DOI":"10.3390\/ijms22158182","volume":"22","author":"Y Gao","year":"2021","unstructured":"Gao Y, Patil S, Jia J. The development of molecular biology of osteoporosis. Int J Mol Sci. 2021;22:8182. https:\/\/doi.org\/10.3390\/ijms22158182.","journal-title":"Int J Mol Sci"},{"key":"3120_CR11","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3390\/biom13030483","volume":"13","author":"Y Gao","year":"2023","unstructured":"Gao Y, Chen N, Fu Z, Zhang Q. Progress of Wnt signaling pathway in osteoporosis. Biomolecules. 2023;13:483. https:\/\/doi.org\/10.3390\/biom13030483.","journal-title":"Biomolecules"},{"key":"3120_CR12","doi-asserted-by":"publisher","first-page":"5776","DOI":"10.3390\/ijms23105776","volume":"23","author":"T Komori","year":"2022","unstructured":"Komori T. Whole aspect of Runx2 functions in skeletal development. Int J Mol Sci. 2022;23:5776. https:\/\/doi.org\/10.3390\/ijms23105776.","journal-title":"Int J Mol Sci"},{"key":"3120_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2022.116353","volume":"159","author":"N Takegahara","year":"2022","unstructured":"Takegahara N, Kim H, Choi Y. RANKL biology. Bone. 2022;159: 116353. https:\/\/doi.org\/10.1016\/j.bone.2022.116353.","journal-title":"Bone"},{"key":"3120_CR14","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1186\/s13018-023-04179-5","volume":"18","author":"G Chi","year":"2023","unstructured":"Chi G, Qiu L, Ma J, Wu W, Zhang Y. The association of osteoprotegerin and RANKL with osteoporosis: a systematic review with meta-analysis. J Orthop Surg Res. 2023;18:839. https:\/\/doi.org\/10.1186\/s13018-023-04179-5.","journal-title":"J Orthop Surg Res"},{"key":"3120_CR15","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/jdb9030024","volume":"9","author":"B Heubel","year":"2021","unstructured":"Heubel B, Nohe A. The role of BMP signaling in osteoclast regulation. J Dev Biol. 2021;9:24. https:\/\/doi.org\/10.3390\/jdb9030024.","journal-title":"J Dev Biol"},{"key":"3120_CR16","doi-asserted-by":"publisher","first-page":"806","DOI":"10.3390\/jcm11030806","volume":"11","author":"ES Vasiliadis","year":"2022","unstructured":"Vasiliadis ES, Evangelopoulos D-S, Kaspiris A, Benetos IS, Vlachos C, Pneumaticos SG. The role of sclerostin in bone diseases. J Clin Med. 2022;11:806. https:\/\/doi.org\/10.3390\/jcm11030806.","journal-title":"J Clin Med"},{"key":"3120_CR17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29367","author":"A Bhatnagar","year":"2022","unstructured":"Bhatnagar A, Kekatpure AL. Postmenopausal osteoporosis: a literature review. Cureus. 2022. https:\/\/doi.org\/10.7759\/cureus.29367.","journal-title":"Cureus"},{"key":"3120_CR18","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.3390\/ijerph19052999","volume":"19","author":"R Khinda","year":"2022","unstructured":"Khinda R, Valecha S, Kumar N, Walia JPS, Singh K, Sethi S, et al. Prevalence and predictors of osteoporosis and osteopenia in postmenopausal women of Punjab, India. Int J Environ Res Public Health. 2022;19:2999. https:\/\/doi.org\/10.3390\/ijerph19052999.","journal-title":"Int J Environ Res Public Health"},{"key":"3120_CR19","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.3390\/ijms23031376","volume":"23","author":"C-H Cheng","year":"2022","unstructured":"Cheng C-H, Chen L-R, Chen K-H. Osteoporosis due to hormone imbalance: an overview of the effects of estrogen deficiency and glucocorticoid overuse on bone turnover. Int J Mol Sci. 2022;23:1376. https:\/\/doi.org\/10.3390\/ijms23031376.","journal-title":"Int J Mol Sci"},{"issue":"Suppl","key":"3120_CR20","first-page":"14","volume":"104","author":"JL Kelsey","year":"1989","unstructured":"Kelsey JL. Risk factors for osteoporosis and associated fractures. Public Health Rep. 1989;104(Suppl):14\u201320.","journal-title":"Public Health Rep"},{"key":"3120_CR21","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1006\/pmed.1994.1123","volume":"23","author":"R Lindsay","year":"1994","unstructured":"Lindsay R. Prevention of Osteoporosis. Prev Med (Baltim). 1994;23:722\u20136. https:\/\/doi.org\/10.1006\/pmed.1994.1123.","journal-title":"Prev Med (Baltim)"},{"key":"3120_CR22","first-page":"92","volume":"43","author":"KN Tu","year":"2018","unstructured":"Tu KN, Lie JD, Wan CKV, Cameron M, Austel AG, Nguyen JK, et al. Osteoporosis: A review of treatment options. P T. 2018;43:92\u2013104.","journal-title":"P T"},{"key":"3120_CR23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5152\/eurjrheum.2016.048","volume":"4","author":"T Sozen","year":"2017","unstructured":"Sozen T, Ozisik L, Calik BN. An overview and management of osteoporosis. Eur J Rheumatol. 2017;4:46\u201356. https:\/\/doi.org\/10.5152\/eurjrheum.2016.048.","journal-title":"Eur J Rheumatol"},{"key":"3120_CR24","doi-asserted-by":"publisher","unstructured":"Curtis EM, Dennison EM, Cooper C, Harvey NC. Osteoporosis in 2022: Care gaps to screening and personalised medicine. Best Pract Res Clin Rheumatol 2022;36. https:\/\/doi.org\/10.1016\/j.berh.2022.101754.","DOI":"10.1016\/j.berh.2022.101754"},{"key":"3120_CR25","doi-asserted-by":"publisher","unstructured":"F\u00f6ger-Samwald U, Dovjak P, Azizi-Semrad U, Kerschan-Schindl K, Pietschmann P. Osteoporosis: Pathophysiology and therapeutic options. EXCLI J 2020;19:1017\u201337. https:\/\/doi.org\/10.17179\/excli2020-2591.","DOI":"10.17179\/excli2020-2591"},{"key":"3120_CR26","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2165\/00003088-199936050-00002","volume":"36","author":"AG Porras","year":"1999","unstructured":"Porras AG, Holland SD, Gertz BJ. Pharmacokinetics of Alendronate. Clin Pharmacokinet. 1999;36:315\u201328. https:\/\/doi.org\/10.2165\/00003088-199936050-00002.","journal-title":"Clin Pharmacokinet"},{"key":"3120_CR27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2147\/cia.s2539","volume":"3","author":"SF Vondracek","year":"2008","unstructured":"Vondracek SF, Minne P, McDermott MT. Clinical challenges in the management of osteoporosis. Clin Interv Aging. 2008;3:315\u201329. https:\/\/doi.org\/10.2147\/cia.s2539.","journal-title":"Clin Interv Aging"},{"key":"3120_CR28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40842-018-0062-7","volume":"4","author":"P Choksi","year":"2018","unstructured":"Choksi P, Jepsen KJ, Clines GA. The challenges of diagnosing osteoporosis and the limitations of currently available tools. Clin Diabetes Endocrinol. 2018;4:12. https:\/\/doi.org\/10.1186\/s40842-018-0062-7.","journal-title":"Clin Diabetes Endocrinol"},{"key":"3120_CR29","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.nantod.2008.10.014","volume":"4","author":"L Zhang","year":"2009","unstructured":"Zhang L, Webster TJ. Nanotechnology and nanomaterials: Promises for improved tissue regeneration. Nano Today. 2009;4:66\u201380. https:\/\/doi.org\/10.1016\/j.nantod.2008.10.014.","journal-title":"Nano Today"},{"key":"3120_CR30","doi-asserted-by":"publisher","unstructured":"Dayanandan AP, Cho WJ, Kang H, Bello AB, Kim BJ, Arai Y, et al. Emerging nano-scale delivery systems for the treatment of osteoporosis. Biomater Res 2023;27. https:\/\/doi.org\/10.1186\/s40824-023-00413-7.","DOI":"10.1186\/s40824-023-00413-7"},{"key":"3120_CR31","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.3390\/nano10091700","volume":"10","author":"S Siddique","year":"2020","unstructured":"Siddique S, Chow JCL. Application of nanomaterials in biomedical imaging and cancer therapy. Nanomaterials. 2020;10:1700. https:\/\/doi.org\/10.3390\/nano10091700.","journal-title":"Nanomaterials"},{"key":"3120_CR32","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.bioactmat.2022.12.014","volume":"24","author":"K Zheng","year":"2023","unstructured":"Zheng K, Bai J, Yang H, Xu Y, Pan G, Wang H, et al. Nanomaterial-assisted theranosis of bone diseases. Bioact Mater. 2023;24:263\u2013312. https:\/\/doi.org\/10.1016\/j.bioactmat.2022.12.014.","journal-title":"Bioact Mater"},{"key":"3120_CR33","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3390\/jnt4030013","volume":"4","author":"K Banerjee","year":"2023","unstructured":"Banerjee K, Madhyastha H. Polymeric theragnostic nanoplatforms for bone tissue engineering. J Nanother. 2023;4:280\u201398. https:\/\/doi.org\/10.3390\/jnt4030013.","journal-title":"J Nanother"},{"key":"3120_CR34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ajps.2020.03.003","volume":"16","author":"PI Siafaka","year":"2021","unstructured":"Siafaka PI, Okur N\u00dc, Karantas ID, Okur ME, G\u00fcndo\u011fdu EA. Current update on nanoplatforms as therapeutic and diagnostic tools: A review for the materials used as nanotheranostics and imaging modalities. Asian J Pharm Sci. 2021;16:24\u201346. https:\/\/doi.org\/10.1016\/j.ajps.2020.03.003.","journal-title":"Asian J Pharm Sci"},{"key":"3120_CR35","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.3390\/molecules25092193","volume":"25","author":"AA Yetisgin","year":"2020","unstructured":"Yetisgin AA, Cetinel S, Zuvin M, Kosar A, Kutlu O. Therapeutic nanoparticles and their targeted delivery applications. Molecules. 2020;25:2193. https:\/\/doi.org\/10.3390\/molecules25092193.","journal-title":"Molecules"},{"key":"3120_CR36","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1021\/acsabm.0c01455","volume":"4","author":"Y Lin","year":"2021","unstructured":"Lin Y, Villacanas MG, Zou H, Liu H, Carcedo IG, Wu Y, et al. Calcium-bisphosphonate nanoparticle platform as a prolonged nanodrug and bone-targeted delivery system for bone diseases and cancers. ACS Appl Bio Mater. 2021;4:2490\u2013501. https:\/\/doi.org\/10.1021\/acsabm.0c01455.","journal-title":"ACS Appl Bio Mater"},{"key":"3120_CR37","doi-asserted-by":"publisher","first-page":"993095","DOI":"10.3389\/fphar.2022.993095","volume":"13","author":"Y Que","year":"2022","unstructured":"Que Y, Yang Y, Zafar H, Wang D. Tetracycline-grafted mPEG-PLGA micelles for bone-targeting and osteoporotic improvement. Front Pharmacol. 2022;13:993095. https:\/\/doi.org\/10.3389\/fphar.2022.993095.","journal-title":"Front Pharmacol"},{"key":"3120_CR38","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bonr.2018.06.007","volume":"9","author":"KB Farrell","year":"2018","unstructured":"Farrell KB, Karpeisky A, Thamm DH, Zinnen S. Bisphosphonate conjugation for bone specific drug targeting. Bone Rep. 2018;9:47\u201360. https:\/\/doi.org\/10.1016\/j.bonr.2018.06.007.","journal-title":"Bone Rep"},{"key":"3120_CR39","doi-asserted-by":"publisher","unstructured":"Coffman AA, Basta\u2010Pljakic J, Guerra RM, Ebetino FH, Lundy MW, Majeska RJ, et al. A Bisphosphonate with a low hydroxyapatite binding affinity prevents bone loss in mice after ovariectomy and reverses rapidly with treatment cessation. JBMR Plus 2021;5. https:\/\/doi.org\/10.1002\/jbm4.10476.","DOI":"10.1002\/jbm4.10476"},{"key":"3120_CR40","doi-asserted-by":"publisher","first-page":"7998","DOI":"10.1021\/acs.nanolett.1c02150","volume":"21","author":"X Zhou","year":"2021","unstructured":"Zhou X, Cornel EJ, Fan Z, He S, Du J. Bone-targeting polymer vesicles for effective therapy of osteoporosis. Nano Lett. 2021;21:7998\u20138007. https:\/\/doi.org\/10.1021\/acs.nanolett.1c02150.","journal-title":"Nano Lett"},{"key":"3120_CR41","first-page":"498","volume":"205","author":"DD Perrin","year":"1965","unstructured":"Perrin DD. Binding of tetracyclines to bone. Nat Publ Group. 1965;205:498\u20139.","journal-title":"Nat Publ Group"},{"key":"3120_CR42","doi-asserted-by":"publisher","first-page":"116377","DOI":"10.1016\/j.bone.2022.116377","volume":"159","author":"AJ Warner","year":"2022","unstructured":"Warner AJ, Hathaway-Schrader JD, Lubker R, Davies C, Novince CM. Tetracyclines and bone: Unclear actions with potentially lasting effects. Bone. 2022;159:116377. https:\/\/doi.org\/10.1016\/j.bone.2022.116377.","journal-title":"Bone"},{"key":"3120_CR43","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.2147\/IJN.S88798","volume":"10","author":"H Wang","year":"2015","unstructured":"Wang H, Liu J, Tao S, Chai G, Wang J, Hu FQ, et al. Tetracycline-grafted PLGA nanoparticles as bone-targeting drug delivery system. Int J Nanomedicine. 2015;10:5671\u201385. https:\/\/doi.org\/10.2147\/IJN.S88798.","journal-title":"Int J Nanomedicine"},{"key":"3120_CR44","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1093\/jac\/dkh191","volume":"53","author":"ESR Darley","year":"2004","unstructured":"Darley ESR, MacGowan AP. Antibiotic treatment of gram-positive bone and joint infections. J Antimicrob Chemother. 2004;53:928\u201335. https:\/\/doi.org\/10.1093\/jac\/dkh191.","journal-title":"J Antimicrob Chemother"},{"key":"3120_CR45","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ajoms.2013.08.001","volume":"27","author":"A Kaya","year":"2015","unstructured":"Kaya A, Kaya B, Aktas A, Firat ET. Effect of rifampin in combination with allogeneic, alloplastic, and heterogenous bone grafts on bone regeneration in rat tibial bone defects. J Oral Maxillofac Surg Med Pathol. 2015;27:20\u20138. https:\/\/doi.org\/10.1016\/j.ajoms.2013.08.001.","journal-title":"J Oral Maxillofac Surg Med Pathol"},{"key":"3120_CR46","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1021\/acsinfecdis.0c00369","volume":"6","author":"I Qayoom","year":"2020","unstructured":"Qayoom I, Teotia AK, Panjla A, Verma S, Kumar A. Local and sustained delivery of rifampicin from a bioactive ceramic carrier treats bone infection in rat Tibia. ACS Infect Dis. 2020;6:2938\u201349. https:\/\/doi.org\/10.1021\/acsinfecdis.0c00369.","journal-title":"ACS Infect Dis"},{"key":"3120_CR47","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S1367-5931(00)00227-1","volume":"5","author":"O Pillai","year":"2001","unstructured":"Pillai O, Panchagnula R. Polymers in drug delivery. Curr Opin Chem Biol. 2001;5:447\u201351. https:\/\/doi.org\/10.1016\/S1367-5931(00)00227-1.","journal-title":"Curr Opin Chem Biol"},{"key":"3120_CR48","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1146\/annurev-chembioeng-073009-100847","volume":"1","author":"WB Liechty","year":"2010","unstructured":"Liechty WB, Kryscio DR, Slaughter BV, Peppas NA. Polymers for drug delivery systems. Annu Rev Chem Biomol Eng. 2010;1:149\u201373. https:\/\/doi.org\/10.1146\/annurev-chembioeng-073009-100847.","journal-title":"Annu Rev Chem Biomol Eng"},{"key":"3120_CR49","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.msec.2015.11.067","volume":"60","author":"F Masood","year":"2016","unstructured":"Masood F. Polymeric nanoparticles for targeted drug delivery system for cancer therapy. Mater Sci Eng, C. 2016;60:569\u201378. https:\/\/doi.org\/10.1016\/j.msec.2015.11.067.","journal-title":"Mater Sci Eng, C"},{"key":"3120_CR50","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3390\/gels9070588","volume":"9","author":"HS Hwang","year":"2023","unstructured":"Hwang HS, Lee C-S. Recent progress in hyaluronic-acid-based hydrogels for bone tissue engineering. Gels. 2023;9:588. https:\/\/doi.org\/10.3390\/gels9070588.","journal-title":"Gels"},{"key":"3120_CR51","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1039\/c5bm00096c","volume":"3","author":"S Kootala","year":"2015","unstructured":"Kootala S, Ossipov D, Van Den Beucken JJJP, Leeuwenburgh S, Hilborn J. Bisphosphonate-functionalized hyaluronic acid showing selective affinity for osteoclasts as a potential treatment for osteoporosis. Biomater Sci. 2015;3:1197\u2013207. https:\/\/doi.org\/10.1039\/c5bm00096c.","journal-title":"Biomater Sci"},{"key":"3120_CR52","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/mabi.200600286","volume":"7","author":"S Zhang","year":"2007","unstructured":"Zhang S, Wright JEI, \u00d6zber N, Uluda\u01e7 H. The interaction of cationic polymers and their bisphosphonate derivatives with hydroxyapatite. Macromol Biosci. 2007;7:656\u201370. https:\/\/doi.org\/10.1002\/mabi.200600286.","journal-title":"Macromol Biosci"},{"key":"3120_CR53","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.3390\/pharmaceutics15061648","volume":"15","author":"B Todaro","year":"2023","unstructured":"Todaro B, Ottalagana E, Luin S, Santi M. Targeting peptides: the new generation of targeted drug delivery systems. Pharmaceutics. 2023;15:1648. https:\/\/doi.org\/10.3390\/pharmaceutics15061648.","journal-title":"Pharmaceutics"},{"key":"3120_CR54","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1021\/bm070121s","volume":"8","author":"MB Murphy","year":"2007","unstructured":"Murphy MB, Hartgerink JD, Goepferich A, Mikos AG. Synthesis and in vitro hydroxyapatite binding of peptides conjugated to calcium-binding moieties. Biomacromol. 2007;8:2237\u201343. https:\/\/doi.org\/10.1021\/bm070121s.","journal-title":"Biomacromol"},{"key":"3120_CR55","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ijpharm.2014.08.067","volume":"475","author":"T Jiang","year":"2014","unstructured":"Jiang T, Yu X, Carbone EJ, Nelson C, Man H, Lo KW. Poly aspartic acid peptide-linked PLGA based nanoscale particles\u202f: Potential for bone-targeting drug delivery applications. Int J Pharm. 2014;475:547\u201357. https:\/\/doi.org\/10.1016\/j.ijpharm.2014.08.067.","journal-title":"Int J Pharm"},{"key":"3120_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics12090885","volume":"12","author":"SG Rotman","year":"2020","unstructured":"Rotman SG, Moriarty TF, Nottelet B, Grijpma DW, Eglin D, Guillaume O. Poly(Aspartic acid) functionalized poly(\u03f5caprolactone) microspheres with enhanced hydroxyapatite affinity as bone targeting antibiotic carriers. Pharmaceutics. 2020;12:1\u201317. https:\/\/doi.org\/10.3390\/pharmaceutics12090885.","journal-title":"Pharmaceutics"},{"key":"3120_CR57","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jconrel.2019.04.042","volume":"304","author":"Y Liu","year":"2019","unstructured":"Liu Y, Yu P, Peng X, Huang Q, Ding M, Chen Y, et al. Hexapeptide-conjugated calcitonin for targeted therapy of osteoporosis. J Control Release. 2019;304:39\u201350. https:\/\/doi.org\/10.1016\/j.jconrel.2019.04.042.","journal-title":"J Control Release"},{"key":"3120_CR58","doi-asserted-by":"publisher","unstructured":"Bang J, Park H, Yoo J, Lee D, Choi W Il, Lee JH, et al. Selection and identification of a novel bone-targeting peptide for biomedical imaging of bone. Sci Rep 2020;10. https:\/\/doi.org\/10.1038\/s41598-020-67522-4.","DOI":"10.1038\/s41598-020-67522-4"},{"key":"3120_CR59","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1128\/JB.00010-12","volume":"195","author":"R Bauer","year":"2013","unstructured":"Bauer R, Wilson JJ, Philominathan STL, Davis D, Matsushita O, Sakona J. Structural comparison of ColH and ColG collagen-binding domains from Clostridium histolyticum. J Bacteriol. 2013;195:318\u201327. https:\/\/doi.org\/10.1128\/JB.00010-12.","journal-title":"J Bacteriol"},{"key":"3120_CR60","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.drudis.2013.07.015","volume":"19","author":"T Ponnapakkam","year":"2014","unstructured":"Ponnapakkam T, Katikaneni R, Sakon J, Stratford R, Gensure RC. Treating osteoporosis by targeting parathyroid hormone to bone. Drug Discov Today. 2014;19:204\u20138. https:\/\/doi.org\/10.1016\/j.drudis.2013.07.015.","journal-title":"Drug Discov Today"},{"key":"3120_CR61","doi-asserted-by":"publisher","first-page":"5759","DOI":"10.1021\/acsnano.5b07828","volume":"10","author":"Y Sun","year":"2016","unstructured":"Sun Y, Ye X, Cai M, Liu X, Xiao J, Zhang C, et al. Osteoblast-targeting-peptide modified nanoparticle for siRNA\/microRNA delivery. ACS Nano. 2016;10:5759\u201368. https:\/\/doi.org\/10.1021\/acsnano.5b07828.","journal-title":"ACS Nano"},{"key":"3120_CR62","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6528\/ad0dc9","volume":"35","author":"Z Pan","year":"2024","unstructured":"Pan Z, Zhang Z, Deng X, Hu F, Jia F, Lu J, et al. Periostin-targeted SDSSD peptide decorated calcium phosphate nanocomposites incorporation with simvastatin for osteoporosis treatment. Nanotechnology. 2024;35: 075102. https:\/\/doi.org\/10.1088\/1361-6528\/ad0dc9.","journal-title":"Nanotechnology"},{"key":"3120_CR63","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jconrel.2023.04.043","volume":"358","author":"L Xu","year":"2023","unstructured":"Xu L, Xu X, Liang Y, Wen C, Ouyang K, Huang J, et al. Osteoclast-targeted delivery of anti-miRNA oligonucleotides by red blood cell extracellular vesicles. J Control Release. 2023;358:259\u201372. https:\/\/doi.org\/10.1016\/j.jconrel.2023.04.043.","journal-title":"J Control Release"},{"key":"3120_CR64","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.3390\/cells11243973","volume":"11","author":"PA Hulley","year":"2022","unstructured":"Hulley PA, Knowles HJ. A new method to sort differentiating osteoclasts into defined homogeneous subgroups. Cells. 2022;11:3973. https:\/\/doi.org\/10.3390\/cells11243973.","journal-title":"Cells"},{"key":"3120_CR65","doi-asserted-by":"publisher","first-page":"16281","DOI":"10.3390\/s150716281","volume":"15","author":"T Ku","year":"2015","unstructured":"Ku T, Zhang T, Luo H, Yen T, Chen P, Han Y, et al. Nucleic acid aptamers: an emerging tool for biotechnology and biomedical sensing. Sensors. 2015;15:16281\u2013313. https:\/\/doi.org\/10.3390\/s150716281.","journal-title":"Sensors"},{"key":"3120_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2022.101529","volume":"45","author":"Y Niu","year":"2022","unstructured":"Niu Y, Yang Y, Yang Z, Wang X, Zhang P, Lv L, et al. Aptamer-immobilized bone-targeting nanoparticles in situ reduce sclerostin for osteoporosis treatment. Nano Today. 2022;45: 101529. https:\/\/doi.org\/10.1016\/j.nantod.2022.101529.","journal-title":"Nano Today"},{"key":"3120_CR67","doi-asserted-by":"publisher","first-page":"5645","DOI":"10.7150\/thno.63177","volume":"12","author":"L Wang","year":"2022","unstructured":"Wang L, Yu Y, Ni S, Li D, Liu J, Xie D, et al. Therapeutic aptamer targeting sclerostin loop3 for promoting bone formation without increasing cardiovascular risk in osteogenesis imperfecta mice. Theranostics. 2022;12:5645\u201374. https:\/\/doi.org\/10.7150\/thno.63177.","journal-title":"Theranostics"},{"key":"3120_CR68","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/nm.3791.Aptamer-functionalized","volume":"21","author":"C Liang","year":"2015","unstructured":"Liang C, Guo B, Wu H, Shao N, Li D, Liu J, et al. Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference\u2013based bone anabolic strategy. Nat Med. 2015;21:288\u201394. https:\/\/doi.org\/10.1038\/nm.3791.Aptamer-functionalized.","journal-title":"Nat Med"},{"key":"3120_CR69","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nrendo.2015.18","volume":"11","author":"J Sargent","year":"2015","unstructured":"Sargent J. Aptamer-lipid nanoparticle conjugates for RNAi in bone. Nat Rev Endocrinol. 2015;11:194. https:\/\/doi.org\/10.1038\/nrendo.2015.18.","journal-title":"Nat Rev Endocrinol"},{"key":"3120_CR70","doi-asserted-by":"publisher","unstructured":"Sheu A, Diamond T. Diagnostic Tests: Bone mineral density: testing for osteoporosis. Aust Prescr 2016;39:35\u20139. https:\/\/doi.org\/10.18773\/austprescr.2016.020.","DOI":"10.18773\/austprescr.2016.020"},{"key":"3120_CR71","doi-asserted-by":"publisher","unstructured":"Lewiecki EM. Evaluation of the osteoporosis patient. Marcus and Feldman\u2019s Osteoporosis, Elsevier; 2021, p. 1475\u2013500. https:\/\/doi.org\/10.1016\/B978-0-12-813073-5.00061-7.","DOI":"10.1016\/B978-0-12-813073-5.00061-7"},{"key":"3120_CR72","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3238\/arztebl.2008.0573","volume":"105","author":"E Baum","year":"2008","unstructured":"Baum E, Peters KM. Prim\u00e4re osteoporose - Leitliniengerechte diagnostik und therapie. Dtsch Arztebl. 2008;105:573\u201382. https:\/\/doi.org\/10.3238\/arztebl.2008.0573.","journal-title":"Dtsch Arztebl"},{"key":"3120_CR73","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2106\/JBJS.I.00919","volume":"92","author":"A Unnanuntana","year":"2010","unstructured":"Unnanuntana A, Gladnick BP, Donnelly E, Lane JM. The assessment of fracture risk. J Bone Joint Surge Am. 2010;92:743\u201353. https:\/\/doi.org\/10.2106\/JBJS.I.00919.","journal-title":"J Bone Joint Surge Am"},{"key":"3120_CR74","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1039\/C8NR07769J","volume":"11","author":"X Han","year":"2019","unstructured":"Han X, Xu K, Taratula O, Farsad K. Applications of nanoparticles in biomedical imaging. Nanoscale. 2019;11:799\u2013819. https:\/\/doi.org\/10.1039\/C8NR07769J.","journal-title":"Nanoscale"},{"key":"3120_CR75","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.3390\/nano13071247","volume":"13","author":"LN Thwala","year":"2023","unstructured":"Thwala LN, Ndlovu SC, Mpofu KT, Lugongolo MY, Mthunzi-Kufa P. Nanotechnology-based diagnostics for diseases prevalent in developing countries: current advances in point-of-care tests. Nanomaterials. 2023;13:1247. https:\/\/doi.org\/10.3390\/nano13071247.","journal-title":"Nanomaterials"},{"key":"3120_CR76","doi-asserted-by":"publisher","first-page":"102700","DOI":"10.1016\/j.jddst.2021.102700","volume":"65","author":"A Singh","year":"2021","unstructured":"Singh A, Mallika TN, Gorain B, Yadav AK, Tiwari S, Flora SJS, et al. Quantum dot: Heralding a brighter future in neurodegenerative disorders. J Drug Deliv Sci Technol. 2021;65:102700. https:\/\/doi.org\/10.1016\/j.jddst.2021.102700.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3120_CR77","doi-asserted-by":"publisher","first-page":"20170022","DOI":"10.1098\/rsta.2017.0022","volume":"375","author":"J Kim","year":"2017","unstructured":"Kim J, Lee N, Hyeon T. Recent development of nanoparticles for molecular imaging. Philosophic Trans Royal Soc A Math Phys Eng Sci. 2017;375:20170022. https:\/\/doi.org\/10.1098\/rsta.2017.0022.","journal-title":"Philosophic Trans Royal Soc A Math Phys Eng Sci"},{"key":"3120_CR78","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1089\/ten.teb.2016.0437","volume":"23","author":"SR Iyer","year":"2017","unstructured":"Iyer SR, Xu S, Stains JP, Bennett CH, Lovering RM. Superparamagnetic iron oxide nanoparticles in musculoskeletal biology. Tissue Eng Part B Rev. 2017;23:373\u201385. https:\/\/doi.org\/10.1089\/ten.teb.2016.0437.","journal-title":"Tissue Eng Part B Rev"},{"key":"3120_CR79","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00339-017-0774-z","volume":"123","author":"JF Sun","year":"2017","unstructured":"Sun JF, Liu X, Guo ZR, Dong J, Huang Y, Zhang J, et al. Exploiting LBL-assembled Au nanoparticles to enhance Raman signals for point-of-care testing of osteoporosis with excreta sample. Appl Phys A. 2017;123:141. https:\/\/doi.org\/10.1007\/s00339-017-0774-z.","journal-title":"Appl Phys A"},{"key":"3120_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4061\/2010\/747852","volume":"2010","author":"Y Lalatonne","year":"2010","unstructured":"Lalatonne Y, Monteil M, Jouni H, Serfaty JM, Sainte-Catherine O, Li\u00e8vre N, et al. Superparamagnetic bifunctional bisphosphonates nanoparticles: a potential mri contrast agent for osteoporosis therapy and diagnostic. J Osteoporos. 2010;2010:1\u20137. https:\/\/doi.org\/10.4061\/2010\/747852.","journal-title":"J Osteoporos"},{"key":"3120_CR81","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10989-013-9373-9","volume":"20","author":"YC Hsiao","year":"2014","unstructured":"Hsiao YC, Chang MH, Chen JJS, Liou CC, Lung FDT. Immunoaffinity nanoprobe-based MALDI-TOF MS for detection of fragments of N-telopeptides of type I collagen. Int J Pept Res Ther. 2014;20:117\u201325. https:\/\/doi.org\/10.1007\/s10989-013-9373-9.","journal-title":"Int J Pept Res Ther"},{"key":"3120_CR82","doi-asserted-by":"publisher","first-page":"619","DOI":"10.2147\/CIA.S405317","volume":"18","author":"D Wang","year":"2023","unstructured":"Wang D, Yang Y. The relationship between serum 25-hydroxyvitamin D levels and osteoporosis in postmenopausal women. Clin Interv Aging. 2023;18:619\u201327. https:\/\/doi.org\/10.2147\/CIA.S405317.","journal-title":"Clin Interv Aging"},{"key":"3120_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.biosx.2022.100124","volume":"10","author":"HS Magar","year":"2022","unstructured":"Magar HS, Brahman PK, Hassan RYA. Biosensors and Bioelectronics\u202f: X Disposable impedimetric nano-immunochips for the early and rapid diagnosis of Vitamin-D deficiency. Biosens Bioelectron X. 2022;10: 100124. https:\/\/doi.org\/10.1016\/j.biosx.2022.100124.","journal-title":"Biosens Bioelectron X"},{"key":"3120_CR84","doi-asserted-by":"publisher","unstructured":"Wang J, Sun G, Li F, Zhu Z, Sun L, Lv P, et al. Development of ZnCdSe\/ZnS quantum dot-based fluorescence immunochromatographic assay for the rapid visual and quantitative detection 25\u2043hydroxyvitamins D in human serum. Front Bioeng Biotechnol 2023;11. https:\/\/doi.org\/10.3389\/fbioe.2023.1326254.","DOI":"10.3389\/fbioe.2023.1326254"},{"key":"3120_CR85","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.glohj.2023.02.008","volume":"7","author":"A Haleem","year":"2023","unstructured":"Haleem A, Javaid M, Singh RP, Rab S, Suman R. Applications of nanotechnology in medical field: a brief review. Global Health J. 2023;7:70\u20137. https:\/\/doi.org\/10.1016\/j.glohj.2023.02.008.","journal-title":"Global Health J"},{"key":"3120_CR86","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202411209","author":"Y Yao","year":"2025","unstructured":"Yao Y, Cui X, Ding S, Wang K, Zhang M. Advances in electrical materials for bone and cartilage regeneration: developments, challenges, and perspectives. Advanced Sci. 2025. https:\/\/doi.org\/10.1002\/advs.202411209.","journal-title":"Advanced Sci"},{"key":"3120_CR87","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1021\/acsbiomaterials.1c01306","volume":"8","author":"Y Deng","year":"2022","unstructured":"Deng Y, Wei W, Tang P. Applications of calcium-based nanomaterials in osteoporosis treatment. ACS Biomater Sci Eng. 2022;8:424\u201343. https:\/\/doi.org\/10.1021\/acsbiomaterials.1c01306.","journal-title":"ACS Biomater Sci Eng"},{"key":"3120_CR88","doi-asserted-by":"publisher","first-page":"530","DOI":"10.3390\/nano11020530","volume":"11","author":"F Salamanna","year":"2021","unstructured":"Salamanna F, Gambardella A, Contartese D, Visani A, Fini M. Nano-based biomaterials as drug delivery systems against osteoporosis: a systematic review of preclinical and clinical evidence. Nanomaterials. 2021;11:530. https:\/\/doi.org\/10.3390\/nano11020530.","journal-title":"Nanomaterials"},{"key":"3120_CR89","doi-asserted-by":"publisher","unstructured":"Cui Y, Lv B, Li Z, Ma C, Gui Z, Geng Y, et al. Bone\u2010targeted biomimetic nanogels re\u2010establish osteoblast\/osteoclast balance to treat postmenopausal osteoporosis. Small 2024;20. https:\/\/doi.org\/10.1002\/smll.202303494.","DOI":"10.1002\/smll.202303494"},{"key":"3120_CR90","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.actbio.2020.12.029","volume":"122","author":"A Pinna","year":"2021","unstructured":"Pinna A, Torki Baghbaderani M, Vigil Hern\u00e1ndez V, Naruphontjirakul P, Li S, McFarlane T, et al. Nanoceria provides antioxidant and osteogenic properties to mesoporous silica nanoparticles for osteoporosis treatment. Acta Biomater. 2021;122:365\u201376. https:\/\/doi.org\/10.1016\/j.actbio.2020.12.029.","journal-title":"Acta Biomater"},{"key":"3120_CR91","unstructured":"Center for Food Safety and Applied Nutrition Office of Cosmetics and Colors. Guidance for Industry Safety of Nanomaterials in Cosmetic. FDA 2014:1\u201316.\u00a0https:\/\/www.regulations.gov\/docket\/FDA-2011-D-0489.\u00a0Accessed 14 Apr 2024."},{"key":"3120_CR92","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.3390\/polym15071596","volume":"15","author":"A Yusuf","year":"2023","unstructured":"Yusuf A, Almotairy ARZ, Henidi H, Alshehri OY, Aldughaim MS. Nanoparticles as drug delivery systems: a review of the implication of nanoparticles\u2019 physicochemical properties on responses in biological systems. Polymers (Basel). 2023;15:1596. https:\/\/doi.org\/10.3390\/polym15071596.","journal-title":"Polymers (Basel)"},{"key":"3120_CR93","doi-asserted-by":"publisher","first-page":"100038","DOI":"10.1016\/j.hsr.2022.100038","volume":"4","author":"M Handa","year":"2022","unstructured":"Handa M, Singh A, Bisht D, Kesharwani P, Shukla R. Potential of particle size less than 15 nm via olfactory region for direct brain delivery via intranasal route. Health Sci Rev. 2022;4:100038. https:\/\/doi.org\/10.1016\/j.hsr.2022.100038.","journal-title":"Health Sci Rev"},{"key":"3120_CR94","doi-asserted-by":"publisher","first-page":"e09394","DOI":"10.1016\/j.heliyon.2022.e09394","volume":"8","author":"H Nsairat","year":"2022","unstructured":"Nsairat H, Khater D, Sayed U, Odeh F, Al Bawab A, Alshaer W. Liposomes: structure, composition, types, and clinical applications. Heliyon. 2022;8:e09394. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e09394.","journal-title":"Heliyon"},{"key":"3120_CR95","doi-asserted-by":"publisher","first-page":"608","DOI":"10.3390\/pharmaceutics15020608","volume":"15","author":"S Salave","year":"2023","unstructured":"Salave S, Shinde SD, Rana D, Sahu B, Kumar H, Patel R, et al. Peptide Engraftment on PEGylated Nanoliposomes for bone specific delivery of PTH (1\u201334) in Osteoporosis. Pharmaceutics. 2023;15:608. https:\/\/doi.org\/10.3390\/pharmaceutics15020608.","journal-title":"Pharmaceutics"},{"key":"3120_CR96","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.xphs.2024.04.005","volume":"113","author":"B Wang","year":"2024","unstructured":"Wang B, Hang H, Wang H, Li D, Jiang Z, Zhang X. Preparation of puerarin long circulating liposomes and its effect on osteoporosis in castrated rats. J Pharm Sci. 2024;113:1823\u201335. https:\/\/doi.org\/10.1016\/j.xphs.2024.04.005.","journal-title":"J Pharm Sci"},{"key":"3120_CR97","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.3390\/pharmaceutics15061593","volume":"15","author":"C Viegas","year":"2023","unstructured":"Viegas C, Patr\u00edcio AB, Prata JM, Nadhman A, Chintamaneni PK, Fonte P. Solid lipid nanoparticles vs. nanostructured lipid carriers: a comparative review. Pharmaceutics. 2023;15:1593. https:\/\/doi.org\/10.3390\/pharmaceutics15061593.","journal-title":"Pharmaceutics"},{"key":"3120_CR98","doi-asserted-by":"publisher","first-page":"103733","DOI":"10.1016\/j.jddst.2022.103733","volume":"75","author":"Z Guo","year":"2022","unstructured":"Guo Z, Qi P, Pei D, Zhang X. Raloxifene-loaded solid lipid nanoparticles decorated gel with enhanced treatment potential of osteoporosis. J Drug Deliv Sci Technol. 2022;75:103733. https:\/\/doi.org\/10.1016\/j.jddst.2022.103733.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3120_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2023.102074","volume":"54","author":"J Liu","year":"2024","unstructured":"Liu J, Zhang Y, Wu Y, Li G, Ji N, Han R, et al. Delivery of m7G methylated Runx2 mRNA by bone-targeted lipid nanoparticle promotes osteoblastic bone formation in senile osteoporosis. Nano Today. 2024;54: 102074. https:\/\/doi.org\/10.1016\/j.nantod.2023.102074.","journal-title":"Nano Today"},{"key":"3120_CR100","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.1021\/acs.chemrev.3c00705","volume":"124","author":"MA Beach","year":"2024","unstructured":"Beach MA, Nayanathara U, Gao Y, Zhang C, Xiong Y, Wang Y, et al. Polymeric nanoparticles for drug delivery. Chem Rev. 2024;124:5505\u2013616. https:\/\/doi.org\/10.1021\/acs.chemrev.3c00705.","journal-title":"Chem Rev"},{"key":"3120_CR101","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12951-021-01231-6","volume":"20","author":"C Zhang","year":"2022","unstructured":"Zhang C, Zhang W, Zhu D, Li Z, Wang Z, Li J, et al. Nanoparticles functionalized with stem cell secretome and CXCR4-overexpressing endothelial membrane for targeted osteoporosis therapy. J Nanobiotechnology. 2022;20:35. https:\/\/doi.org\/10.1186\/s12951-021-01231-6.","journal-title":"J Nanobiotechnology"},{"key":"3120_CR102","doi-asserted-by":"publisher","first-page":"119038","DOI":"10.1016\/j.ijpharm.2020.119038","volume":"577","author":"WK Delan","year":"2020","unstructured":"Delan WK, Zakaria M, Elsaadany B, ElMeshad AN, Mamdouh W, Fares AR. Formulation of simvastatin chitosan nanoparticles for controlled delivery in bone regeneration: Optimization using Box-Behnken design, stability and in vivo study. Int J Pharm. 2020;577:119038. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119038.","journal-title":"Int J Pharm"},{"key":"3120_CR103","doi-asserted-by":"publisher","first-page":"107584","DOI":"10.1016\/j.polymertesting.2022.107584","volume":"110","author":"C Jing","year":"2022","unstructured":"Jing C, Chen S, Bhatia SS, Li B, Liang H, Liu C, et al. Bone-targeted polymeric nanoparticles as alendronate carriers for potential osteoporosis treatment. Polym Test. 2022;110:107584. https:\/\/doi.org\/10.1016\/j.polymertesting.2022.107584.","journal-title":"Polym Test"},{"key":"3120_CR104","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1080\/10717544.2022.2111479","volume":"29","author":"S-J Yang","year":"2022","unstructured":"Yang S-J, Chang C-H, Young T-H, Wang C-H, Tseng T-H, Wang M-L. Human serum albumin-based nanoparticles alter raloxifene administration and improve bioavailability. Drug Deliv. 2022;29:2685\u201393. https:\/\/doi.org\/10.1080\/10717544.2022.2111479.","journal-title":"Drug Deliv"},{"key":"3120_CR105","doi-asserted-by":"publisher","first-page":"6652","DOI":"10.3390\/molecules28186652","volume":"28","author":"M Ma","year":"2023","unstructured":"Ma M, Zeng H, Yang P, Xu J, Zhang X, He W. Drug delivery and therapy strategies for osteoporosis intervention. Molecules. 2023;28:6652. https:\/\/doi.org\/10.3390\/molecules28186652.","journal-title":"Molecules"},{"key":"3120_CR106","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1080\/10717544.2017.1347966","volume":"24","author":"Y Xie","year":"2017","unstructured":"Xie Y, Tan X, Huang J, Huang H, Zou P, Hu J. Atorvastatin-loaded micelles with bone-targeted ligand for the treatment of osteoporosis. Drug Deliv. 2017;24:1067\u201376. https:\/\/doi.org\/10.1080\/10717544.2017.1347966.","journal-title":"Drug Deliv"},{"key":"3120_CR107","doi-asserted-by":"publisher","first-page":"045005","DOI":"10.1088\/1748-605X\/acd15b","volume":"18","author":"J Zhang","year":"2023","unstructured":"Zhang J, Li X, Xia X, Adu-Frimpong M, Shen X, He Q, et al. Vitexin loaded mixed polymeric micelles: preparation, optimization, evaluation and anti-osteoporotic effect. Biomed Mater. 2023;18:045005. https:\/\/doi.org\/10.1088\/1748-605X\/acd15b.","journal-title":"Biomed Mater"},{"key":"3120_CR108","doi-asserted-by":"publisher","unstructured":"P\u00e9rez-Ferreiro M, M. Abelairas A, Criado A, G\u00f3mez IJ, Mosquera J. Dendrimers: exploring their wide structural variety and applications. Polymers (Basel) 2023;15:4369. https:\/\/doi.org\/10.3390\/polym15224369.","DOI":"10.3390\/polym15224369"},{"key":"3120_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2022.113029","volume":"222","author":"X Yang","year":"2023","unstructured":"Yang X, Kuang Z, Yang X, Hu X, Luo P, Lai Q, et al. Facile synthesis of curcumin-containing poly(amidoamine) dendrimers as pH-responsive delivery system for osteoporosis treatment. Colloids Surf B Biointerfaces. 2023;222: 113029. https:\/\/doi.org\/10.1016\/j.colsurfb.2022.113029.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"3120_CR110","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3390\/pharmaceutics14040770","volume":"14","author":"A-C Burdu\u0219el","year":"2022","unstructured":"Burdu\u0219el A-C, Gherasim O, Andronescu E, Grumezescu AM, Ficai A. Inorganic nanoparticles in bone healing applications. Pharmaceutics. 2022;14:770. https:\/\/doi.org\/10.3390\/pharmaceutics14040770.","journal-title":"Pharmaceutics"},{"key":"3120_CR111","doi-asserted-by":"publisher","unstructured":"Zipkin I. The Inorganic Composition of Bones and Teeth. Biological Calcification: Cellular and Molecular Aspects, Boston, MA: Springer US; 1970, p. 69\u2013103. https:\/\/doi.org\/10.1007\/978-1-4684-8485-4_3.","DOI":"10.1007\/978-1-4684-8485-4_3"},{"key":"3120_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2023.144145","volume":"470","author":"Y Huang","year":"2023","unstructured":"Huang Y, Chen M, Shen Y, Shen X, Li M, Li Y, et al. Bone-targeting cell membrane-engineered CaCO3-based nanoparticles restore local bone homeostasis for microenvironment-responsive osteoporosis treatment. Chem Eng J. 2023;470: 144145. https:\/\/doi.org\/10.1016\/j.cej.2023.144145.","journal-title":"Chem Eng J"},{"key":"3120_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104278","volume":"81","author":"PS Priya","year":"2023","unstructured":"Priya PS, Vaishnavi S, Pavithra V, Pachaiappan R, Barathkumar S, Almutairi BO, et al. Graphene oxide decorated daidzein as an oral drug to ameliorate the oxidative stress and glucocorticoid-induced osteoporosis in vivo zebrafish model. J Drug Deliv Sci Technol. 2023;81: 104278. https:\/\/doi.org\/10.1016\/j.jddst.2023.104278.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3120_CR114","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.3390\/ma11081430","volume":"11","author":"S Prasadh","year":"2018","unstructured":"Prasadh S, Suresh S, Wong R. Osteogenic potential of graphene in bone tissue engineering scaffolds. Materials. 2018;11:1430. https:\/\/doi.org\/10.3390\/ma11081430.","journal-title":"Materials"},{"key":"3120_CR115","doi-asserted-by":"publisher","unstructured":"Liu X, Li F, Dong Z, Gu C, Mao D, Chen J, et al. Metal-polyDNA nanoparticles reconstruct osteoporotic microenvironment for enhanced osteoporosis treatment. Sci Adv 2023;9. https:\/\/doi.org\/10.1126\/sciadv.adf3329.","DOI":"10.1126\/sciadv.adf3329"},{"key":"3120_CR116","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12951-023-01872-9","volume":"21","author":"Y Chen","year":"2023","unstructured":"Chen Y, Yang C, Dai Q, Tan J, Dou C, Luo F. Gold-nanosphere mitigates osteoporosis through regulating TMAO metabolism in a gut microbiota-dependent manner. J Nanobiotechnology. 2023;21:125. https:\/\/doi.org\/10.1186\/s12951-023-01872-9.","journal-title":"J Nanobiotechnology"},{"key":"3120_CR117","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3390\/pharmaceutics13040462","volume":"13","author":"D Lee","year":"2021","unstructured":"Lee D, Ko W-K, Kim SJ, Han I-B, Hong JB, Sheen SH, et al. Inhibitory effects of gold and silver nanoparticles on the differentiation into osteoclasts in vitro. Pharmaceutics. 2021;13:462. https:\/\/doi.org\/10.3390\/pharmaceutics13040462.","journal-title":"Pharmaceutics"},{"key":"3120_CR118","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.jconrel.2022.12.027","volume":"353","author":"J Mondal","year":"2023","unstructured":"Mondal J, Pillarisetti S, Junnuthula V, Saha M, Hwang SR, Park I, et al. Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications. J Control Release. 2023;353:1127\u201349. https:\/\/doi.org\/10.1016\/j.jconrel.2022.12.027.","journal-title":"J Control Release"},{"key":"3120_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.123079","volume":"357","author":"Z Xing","year":"2024","unstructured":"Xing Z, Guo L, Li S, Huang W, Su J, Chen X, et al. Skeletal muscle-derived exosomes prevent osteoporosis by promoting osteogenesis. Life Sci. 2024;357: 123079. https:\/\/doi.org\/10.1016\/j.lfs.2024.123079.","journal-title":"Life Sci"},{"key":"3120_CR120","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.26355\/eurrev_201902_17014","volume":"23","author":"Y Xie","year":"2019","unstructured":"Xie Y, Hu J-H, Wu H, Huang Z-Z, Yan H-W, Shi Z-Y. Bone marrow stem cells derived exosomes improve osteoporosis by promoting osteoblast proliferation and inhibiting cell apoptosis. Eur Rev Med Pharmacol Sci. 2019;23:1214\u201320. https:\/\/doi.org\/10.26355\/eurrev_201902_17014.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3120_CR121","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s10020-024-00904-w","volume":"30","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Bai J, Xiao B, Li C. BMSC-derived exosomes promote osteoporosis alleviation via M2 macrophage polarization. Mol Med. 2024;30:220. https:\/\/doi.org\/10.1186\/s10020-024-00904-w.","journal-title":"Mol Med"},{"key":"3120_CR122","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.26355\/eurrev_201806_15280","volume":"22","author":"P Zhao","year":"2018","unstructured":"Zhao P, Xiao L, Peng J, Qian Y-Q, Huang C-C. Exosomes derived from bone marrow mesenchymal stem cells improve osteoporosis through promoting osteoblast proliferation via MAPK pathway. Eur Rev Med Pharmacol Sci. 2018;22:3962\u201370. https:\/\/doi.org\/10.26355\/eurrev_201806_15280.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3120_CR123","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1089\/ten.teb.2020.0168","volume":"27","author":"Z Zheng","year":"2021","unstructured":"Zheng Z, Yu C, Wei H. Injectable hydrogels as three-dimensional network reservoirs for osteoporosis treatment. Tissue Eng Part B Rev. 2021;27:430\u201354. https:\/\/doi.org\/10.1089\/ten.teb.2020.0168.","journal-title":"Tissue Eng Part B Rev"},{"key":"3120_CR124","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.msec.2015.07.053","volume":"57","author":"F Ullah","year":"2015","unstructured":"Ullah F, Othman MBH, Javed F, Ahmad Z, Akil HM. Classification, processing and application of hydrogels: A review. Mater Sci Eng, C. 2015;57:414\u201333. https:\/\/doi.org\/10.1016\/j.msec.2015.07.053.","journal-title":"Mater Sci Eng, C"},{"key":"3120_CR125","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/s41557-024-01476-2","volume":"16","author":"J Liu","year":"2024","unstructured":"Liu J, Huang YS, Liu Y, Zhang D, Koynov K, Butt HJ, et al. Reconfiguring hydrogel assemblies using a photocontrolled metallopolymer adhesive for multiple customized functions. Nat Chem. 2024;16:1024\u201333. https:\/\/doi.org\/10.1038\/s41557-024-01476-2.","journal-title":"Nat Chem"},{"key":"3120_CR126","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.job.2017.05.001","volume":"59","author":"M Nakamura","year":"2017","unstructured":"Nakamura M, Nakamichi Y, Mizoguchi T, Koide M, Yamashita T, Ara T, et al. The W9 peptide directly stimulates osteoblast differentiation via RANKL signaling. J Oral Biosci. 2017;59:146\u201351. https:\/\/doi.org\/10.1016\/j.job.2017.05.001.","journal-title":"J Oral Biosci"},{"key":"3120_CR127","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4155\/tde.14.111","volume":"6","author":"AL Lewis","year":"2015","unstructured":"Lewis AL, Richard J. Challenges in the Delivery of Peptide drugs: an Industry Perspective. Ther Deliv. 2015;6:149\u201363. https:\/\/doi.org\/10.4155\/tde.14.111.","journal-title":"Ther Deliv"},{"key":"3120_CR128","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejps.2009.01.002","volume":"37","author":"N Alles","year":"2009","unstructured":"Alles N, Soysa NS, Hussain MA, Tomomatsu N, Saito H, Baron R, et al. Polysaccharide nanogel delivery of a TNF-\u03b1 and RANKL antagonist peptide allows systemic prevention of bone loss. Eur J Pharm Sci. 2009;37:83\u20138. https:\/\/doi.org\/10.1016\/j.ejps.2009.01.002.","journal-title":"Eur J Pharm Sci"},{"key":"3120_CR129","doi-asserted-by":"publisher","first-page":"126380","DOI":"10.1016\/j.ijbiomac.2023.126380","volume":"251","author":"B Haroon","year":"2023","unstructured":"Haroon B, Sohail M, Minhas MU, Mahmood A, Hussain Z, Ahmed Shah S, et al. Nano-residronate loaded \u03ba-carrageenan-based injectable hydrogels for bone tissue regeneration. Int J Biol Macromol. 2023;251:126380. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.126380.","journal-title":"Int J Biol Macromol"},{"key":"3120_CR130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-19968-x","volume":"12","author":"MD Patrick","year":"2022","unstructured":"Patrick MD, Keys JF, Suresh Kumar H, Annamalai RT. Injectable nanoporous microgels generate vascularized constructs and support bone regeneration in critical-sized defects. Sci Rep. 2022;12:1\u201318. https:\/\/doi.org\/10.1038\/s41598-022-19968-x.","journal-title":"Sci Rep"},{"key":"3120_CR131","doi-asserted-by":"publisher","first-page":"17234","DOI":"10.1021\/acsami.9b03173","volume":"11","author":"L Kuang","year":"2019","unstructured":"Kuang L, Ma X, Ma Y, Yao Y, Tariq M, Yuan Y, et al. Self-Assembled injectable nanocomposite hydrogels coordinated by in situ generated CaP nanoparticles for bone regeneration. ACS Appl Mater Interfaces. 2019;11:17234\u201346. https:\/\/doi.org\/10.1021\/acsami.9b03173.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3120_CR132","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/jbm.a.35980","volume":"105","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Chen X, Geng S, Wei L, Miron RJ, Zhao Y, et al. Nanogel-based scaffolds fabricated for bone regeneration with mesoporous bioactive glass and strontium: In vitro and in vivo characterization. J Biomed Mater Res A. 2017;105:1175\u201383. https:\/\/doi.org\/10.1002\/jbm.a.35980.","journal-title":"J Biomed Mater Res A"},{"key":"3120_CR133","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2055-7124-18-5","volume":"18","author":"KC Gupta","year":"2014","unstructured":"Gupta KC, Haider A, Choi YR, Kang IK. Nanofibrous scaffolds in biomedical applications. Biomater Res. 2014;18:1\u201311. https:\/\/doi.org\/10.1186\/2055-7124-18-5.","journal-title":"Biomater Res"},{"key":"3120_CR134","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1007\/s10439-021-02810-2","volume":"49","author":"KE Mosaad","year":"2021","unstructured":"Mosaad KE, Shoueir KR, Saied AH, Dewidar MM. New prospects in nano phased co-substituted hydroxyapatite enrolled in polymeric nanofiber mats for bone tissue engineering applications. Ann Biomed Eng. 2021;49:2006\u201329. https:\/\/doi.org\/10.1007\/s10439-021-02810-2.","journal-title":"Ann Biomed Eng"},{"key":"3120_CR135","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1002\/ptr.5693","volume":"30","author":"M Imenshahidi","year":"2016","unstructured":"Imenshahidi M, Hosseinzadeh H. Berberis vulgaris and berberine: an update review. Phytother Res. 2016;30:1745\u201364. https:\/\/doi.org\/10.1002\/ptr.5693.","journal-title":"Phytother Res"},{"key":"3120_CR136","unstructured":"Ghareeb DA, El-Rashidy FH, El-Mallawany S. Imbalanced Diet Deficient in Calcium and Vitamin D-Induced Juvenile Osteopenia in Rats; the Potential Therapeutic Effect of Egyptian Moghat Roots Water Extract (Glossostemon bruguieri). 2014;14."},{"key":"3120_CR137","doi-asserted-by":"publisher","unstructured":"Shaban NZ, Kenawy MY, Taha NA, Abd El-Latif MM, Ghareeb DA. Cellulose acetate nanofibers: Incorporating hydroxyapatite (ha), ha\/berberine or ha\/moghat composites, as scaffolds to enhance in vitro osteoporotic bone regeneration. Polymers (Basel) 2021;13. https:\/\/doi.org\/10.3390\/polym13234140.","DOI":"10.3390\/polym13234140"},{"key":"3120_CR138","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.dental.2014.08.381","volume":"30","author":"Y Ji","year":"2014","unstructured":"Ji Y, Wang L, Watts DC, Qiu H, You T, Deng F, et al. Controlled-release naringin nanoscaffold for osteoporotic bone healing. Dent Mater. 2014;30:1263\u201373. https:\/\/doi.org\/10.1016\/j.dental.2014.08.381.","journal-title":"Dent Mater"},{"key":"3120_CR139","doi-asserted-by":"publisher","unstructured":"Al-Baadani MA, Xu L, Hii Ru Yie K, Sun A, Gao X, Cai K, et al. In situ preparation of alendronate-loaded ZIF-8 nanoparticles on electrospun nanofibers for accelerating early osteogenesis in osteoporosis. Mater Des 2022;217:110596. https:\/\/doi.org\/10.1016\/j.matdes.2022.110596.","DOI":"10.1016\/j.matdes.2022.110596"},{"key":"3120_CR140","doi-asserted-by":"publisher","first-page":"5941","DOI":"10.2147\/IJN.S90669","volume":"10","author":"MH Ho","year":"2015","unstructured":"Ho MH, Yao CJ, Liao MH, Lin PI, Liu SH, Chen RM. Chitosan nanofiber scaffold improves bone healing via stimulating trabecular bone production due to upregulation of the Runx2\/osteocalcin\/alkaline phosphatase signaling pathway. Int J Nanomedicine. 2015;10:5941\u201354. https:\/\/doi.org\/10.2147\/IJN.S90669.","journal-title":"Int J Nanomedicine"},{"key":"3120_CR141","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.spinee.2016.10.001","volume":"17","author":"MN Erdem","year":"2017","unstructured":"Erdem MN, Karaca S, Sar\u0131 S, Yumrukcal F, Tanli R, Aydogan M. Application of cement on strategic vertebrae in the treatment of the osteoporotic spine. The Spine Journal. 2017;17:328\u201337. https:\/\/doi.org\/10.1016\/j.spinee.2016.10.001.","journal-title":"The Spine Journal"},{"key":"3120_CR142","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1023\/A:1026394530192","volume":"14","author":"SM Kenny","year":"2003","unstructured":"Kenny SM, Buggy M. Bone cements and fillers: A review. J Mater Sci Mater Med. 2003;14:923\u201338. https:\/\/doi.org\/10.1023\/A:1026394530192.","journal-title":"J Mater Sci Mater Med"},{"key":"3120_CR143","doi-asserted-by":"publisher","unstructured":"Groenendijk I, van Delft M, Versloot P, van Loon LJC, de Groot LCPGM. Impact of magnesium on bone health in older adults: A systematic review and meta-analysis. Bone 2022;154:116233. https:\/\/doi.org\/10.1016\/j.bone.2021.116233.","DOI":"10.1016\/j.bone.2021.116233"},{"key":"3120_CR144","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-024-53084-2","volume":"14","author":"S Gamal","year":"2024","unstructured":"Gamal S, Mikhail M, Salem N, El-Wakad MT, Abdelbaset R. Effect of using nano-particles of magnesium oxide and titanium dioxide to enhance physical and mechanical properties of hip joint bone cement. Sci Rep. 2024;14:1\u201314. https:\/\/doi.org\/10.1038\/s41598-024-53084-2.","journal-title":"Sci Rep"},{"key":"3120_CR145","doi-asserted-by":"crossref","unstructured":"Lin X, Ge J, Wei D, Liu C, Tan L. ScienceDirect Surface degradation e enabled osseointegrative , angiogenic and antiinfective properties of magnesium- modified acrylic bone cement 2019.","DOI":"10.1016\/j.jot.2019.04.007"},{"key":"3120_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2014.04.020","author":"B Kanter","year":"2014","unstructured":"Kanter B, Geffers M, Ignatius A, Gbureck U. Control of in vivo mineral bone cement degradation. Acta Biomater. 2014. https:\/\/doi.org\/10.1016\/j.actbio.2014.04.020.","journal-title":"Acta Biomater"},{"key":"3120_CR147","unstructured":"Watkins AW, Anseth KS. Journal of Biomaterials Science, Polymer Edition Copolymerization of photocrosslinkable anhydride monomers for use as a biodegradable bone cement 2012:37\u201341."},{"key":"3120_CR148","doi-asserted-by":"publisher","first-page":"29213","DOI":"10.1016\/j.ceramint.2021.07.086","volume":"47","author":"Z Cai","year":"2021","unstructured":"Cai Z, Wu Z, Wan Y, Yu T, Zhou C. Manipulation of the degradation behavior of calcium phosphate and calcium sulfate bone cement system by the addition of micro-nano calcium phosphate. Ceram Int. 2021;47:29213\u201324. https:\/\/doi.org\/10.1016\/j.ceramint.2021.07.086.","journal-title":"Ceram Int"},{"key":"3120_CR149","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1021\/acs.biomac.9b01327","volume":"21","author":"I Qayoom","year":"2020","unstructured":"Qayoom I, Teotia AK, Kumar A. Nanohydroxyapatite based ceramic carrier promotes bone formation in a femoral neck canal defect in osteoporotic rats. Biomacromol. 2020;21:328\u201337. https:\/\/doi.org\/10.1021\/acs.biomac.9b01327.","journal-title":"Biomacromol"},{"key":"3120_CR150","doi-asserted-by":"publisher","first-page":"121025","DOI":"10.1016\/j.biomaterials.2021.121025","volume":"276","author":"NH Lee","year":"2021","unstructured":"Lee NH, Kang MS, Kim TH, Yoon DS, Mandakhbayar N, Jo SB, et al. Dual actions of osteoclastic-inhibition and osteogenic-stimulation through strontium-releasing bioactive nanoscale cement imply biomaterial-enabled osteoporosis therapy. Biomaterials. 2021;276:121025. https:\/\/doi.org\/10.1016\/j.biomaterials.2021.121025.","journal-title":"Biomaterials"},{"key":"3120_CR151","doi-asserted-by":"publisher","unstructured":"Li M, Fu S, Cai Z, Li D, Liu L, Deng D, et al. Dual regulation of osteoclastogenesis and osteogenesis for osteoporosis therapy by iron oxide hydroxyapatite core\/shell nanocomposites. Regen Biomater 2021;8. https:\/\/doi.org\/10.1093\/rb\/rbab027.","DOI":"10.1093\/rb\/rbab027"},{"key":"3120_CR152","doi-asserted-by":"publisher","unstructured":"Feng H, Zhao C, Tan P, Liu R, Chen X, Li Z. Nanogenerator for biomedical applications. Adv Healthc Mater 2018;7. https:\/\/doi.org\/10.1002\/adhm.201701298.","DOI":"10.1002\/adhm.201701298"},{"key":"3120_CR153","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/aenm.201802906","volume":"9","author":"C Wu","year":"2019","unstructured":"Wu C, Wang AC, Ding W, Guo H, Wang ZL. Triboelectric Nanogenerator: A Foundation of the Energy for the New Era. Adv Energy Mater. 2019;9:1\u201325. https:\/\/doi.org\/10.1002\/aenm.201802906.","journal-title":"Adv Energy Mater"},{"key":"3120_CR154","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/bem.22187","volume":"40","author":"C Galli","year":"2019","unstructured":"Galli C, Pedrazzi G, Guizzardi S. The cellular effects of Pulsed Electromagnetic Fields on osteoblasts: A review. Bioelectromagnetics. 2019;40:211\u201333. https:\/\/doi.org\/10.1002\/bem.22187.","journal-title":"Bioelectromagnetics"},{"key":"3120_CR155","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.ultrasmedbio.2006.01.017","volume":"32","author":"J Kuan-Jung Li","year":"2006","unstructured":"Kuan-Jung Li J, Cheng-An Lin J, Liu HC, Sun JS, Ruaan RC, Shih C, et al. Comparison of ultrasound and electromagnetic field effects on osteoblast growth. Ultrasound Med Biol. 2006;32:769\u201375. https:\/\/doi.org\/10.1016\/j.ultrasmedbio.2006.01.017.","journal-title":"Ultrasound Med Biol"},{"key":"3120_CR156","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1021\/acsaem.8b00530","volume":"1","author":"N Cui","year":"2018","unstructured":"Cui N, Liu J, Lei Y, Gu L, Xu Q, Liu S, et al. High-performance triboelectric nanogenerator with a rationally designed friction layer structure. ACS Appl Energy Mater. 2018;1:2891\u20137. https:\/\/doi.org\/10.1021\/acsaem.8b00530.","journal-title":"ACS Appl Energy Mater"},{"key":"3120_CR157","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.nanoen.2019.02.073","volume":"59","author":"J Tian","year":"2019","unstructured":"Tian J, Shi R, Liu Z, Ouyang H, Yu M, Zhao C, et al. Self-powered implantable electrical stimulator for osteoblasts\u2019 proliferation and differentiation. Nano Energy. 2019;59:705\u201314. https:\/\/doi.org\/10.1016\/j.nanoen.2019.02.073.","journal-title":"Nano Energy"},{"key":"3120_CR158","doi-asserted-by":"publisher","first-page":"7867","DOI":"10.1021\/acsnano.5b03567","volume":"9","author":"W Tang","year":"2015","unstructured":"Tang W, Tian J, Zheng Q, Yan L, Wang J, Li Z, et al. Implantable self-powered low-level laser cure system for mouse embryonic osteoblasts\u2019 proliferation and differentiation. ACS Nano. 2015;9:7867\u201373. https:\/\/doi.org\/10.1021\/acsnano.5b03567.","journal-title":"ACS Nano"},{"key":"3120_CR159","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s11426-020-9945-4","volume":"64","author":"C Zhang","year":"2021","unstructured":"Zhang C, Li Y, Ma X, He W, Liu C, Liu Z. Functional micro\/nanobubbles for ultrasound medicine and visualizable guidance. Sci China Chem. 2021;64:899\u2013914. https:\/\/doi.org\/10.1007\/s11426-020-9945-4.","journal-title":"Sci China Chem"},{"key":"3120_CR160","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s00198-016-3830-1","volume":"28","author":"T Noguchi","year":"2017","unstructured":"Noguchi T, Ebina K, Hirao M, Morimoto T, Koizumi K, Kitaguchi K, et al. Oxygen ultra-fine bubbles water administration prevents bone loss of glucocorticoid-induced osteoporosis in mice by suppressing osteoclast differentiation. Osteoporos Int. 2017;28:1063\u201375. https:\/\/doi.org\/10.1007\/s00198-016-3830-1.","journal-title":"Osteoporos Int"},{"key":"3120_CR161","doi-asserted-by":"publisher","unstructured":"Knowles HJ, Vasilyeva A, Sheth M, Pattinson O, May J, Rumney RMH, et al. Use of oxygen-loaded nanobubbles to improve tissue oxygenation: Bone-relevant mechanisms of action and effects on osteoclast differentiation. Biomaterials 2024;305. https:\/\/doi.org\/10.1016\/j.biomaterials.2023.122448.","DOI":"10.1016\/j.biomaterials.2023.122448"},{"key":"3120_CR162","doi-asserted-by":"publisher","unstructured":"Bagha S, Kolanthai P;, Wei E;, Neal F;, Sotoudeh Bagha P, Kolanthai E, et al. Citation: Ultrasound-Responsive Nanobubbles for Combined siRNA-Cerium Oxide Nanoparticle Delivery to Bone Cells 2023. https:\/\/doi.org\/10.3390\/pharmaceutics.","DOI":"10.3390\/pharmaceutics"},{"key":"3120_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104493","volume":"84","author":"S Shukla","year":"2023","unstructured":"Shukla S, Mamale KB, Arya RKK, Kaundal RK, Shukla R. Therapeutic potential of microneedles based delivery systems for the management of atopic dermatitis. J Drug Deliv Sci Technol. 2023;84: 104493. https:\/\/doi.org\/10.1016\/j.jddst.2023.104493.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3120_CR164","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1080\/02652048.2024.2373723","volume":"41","author":"A Rohila","year":"2024","unstructured":"Rohila A, Shukla R. Recent advancements in microspheres mediated targeted delivery for therapeutic interventions in osteoarthritis. J Microencapsul. 2024;41:434\u201355. https:\/\/doi.org\/10.1080\/02652048.2024.2373723.","journal-title":"J Microencapsul"},{"key":"3120_CR165","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/1061186X.2020.1797052","volume":"29","author":"G Tezel","year":"2021","unstructured":"Tezel G, Timur SS, Kuralay F, G\u00fcrsoy RN, Ulubayram K, \u00d6ner L, et al. Current status of micro\/nanomotors in drug delivery. J Drug Target. 2021;29:29\u201345. https:\/\/doi.org\/10.1080\/1061186X.2020.1797052.","journal-title":"J Drug Target"},{"key":"3120_CR166","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/JS9.0000000000001280","volume":"10","author":"F Hu","year":"2024","unstructured":"Hu F, Liang H, Xie J, Yuan M, Huang W, Lei Y, et al. A novel shockwave-driven nano-motor composite microneedle transdermal delivery system for the localized treatment of osteoporosis: a basic science study. Int J Surge. 2024;10:10\u20131097. https:\/\/doi.org\/10.1097\/JS9.0000000000001280.","journal-title":"Int J Surge"},{"key":"3120_CR167","doi-asserted-by":"publisher","first-page":"123335","DOI":"10.1016\/j.ijpharm.2023.123335","volume":"644","author":"N Sultana","year":"2023","unstructured":"Sultana N, Ali A, Waheed A, Jabi B, Yaqub KM, Mujeeb M, et al. Dissolving microneedle transdermal patch loaded with Risedronate sodium and Ursolic acid bipartite nanotransfersomes to combat osteoporosis: Optimization, characterization, in vitro and ex vivo assessment. Int J Pharm. 2023;644:123335. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123335.","journal-title":"Int J Pharm"},{"key":"3120_CR168","doi-asserted-by":"publisher","first-page":"39782","DOI":"10.1021\/acsomega.2c03762","volume":"7","author":"A Zaid Alkilani","year":"2022","unstructured":"Zaid Alkilani A, Hamed R, Abdo H, Swellmeen L, Basheer HA, Wahdan W, et al. Formulation and evaluation of azithromycin-loaded niosomal gel: optimization, in vitro studies, rheological characterization, and cytotoxicity study. ACS Omega. 2022;7:39782\u201393. https:\/\/doi.org\/10.1021\/acsomega.2c03762.","journal-title":"ACS Omega"},{"key":"3120_CR169","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jconrel.2021.11.043","volume":"341","author":"A Hope","year":"2022","unstructured":"Hope A, Wade SJ, Aghmesheh M, Vine KL. Localized delivery of immunotherapy via implantable scaffolds for breast cancer treatment. J Contr Release. 2022;341:399\u2013413. https:\/\/doi.org\/10.1016\/j.jconrel.2021.11.043.","journal-title":"J Contr Release"},{"key":"3120_CR170","doi-asserted-by":"publisher","unstructured":"Ray P, Hasnain MS, Koley A, Nayak AK. Bone-implantable devices for drug delivery applications. Bioelectronics and Medical Devices, Elsevier; 2019, p. 355\u201392. https:\/\/doi.org\/10.1016\/B978-0-08-102420-1.00021-2.","DOI":"10.1016\/B978-0-08-102420-1.00021-2"},{"key":"3120_CR171","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.actbio.2019.10.033","volume":"101","author":"L Casarrubios","year":"2020","unstructured":"Casarrubios L, G\u00f3mez-Cerezo N, S\u00e1nchez-Salcedo S, Feito MJ, Serrano MC, Saiz-Pardo M, et al. Silicon substituted hydroxyapatite\/VEGF scaffolds stimulate bone regeneration in osteoporotic sheep. Acta Biomater. 2020;101:544\u201353. https:\/\/doi.org\/10.1016\/j.actbio.2019.10.033.","journal-title":"Acta Biomater"},{"key":"3120_CR172","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-022-01277-0","volume":"20","author":"W Wang","year":"2022","unstructured":"Wang W, Xiong Y, Zhao R, Li X, Jia W. A novel hierarchical biofunctionalized 3D-printed porous Ti6Al4V scaffold with enhanced osteoporotic osseointegration through osteoimmunomodulation. J Nanobiotechnology. 2022;20:1\u201319. https:\/\/doi.org\/10.1186\/s12951-022-01277-0.","journal-title":"J Nanobiotechnology"},{"key":"3120_CR173","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.121001","volume":"309","author":"N Mohamed","year":"2022","unstructured":"Mohamed N, Elsayyad E, Gomaa I, Salem MA, Amer R, El-laithy HM. Efficient lung-targeted delivery of risedronate sodium \/ vitamin D3 conjugated PAMAM-G5 dendrimers for managing osteoporosis\u202f: Pharmacodynamics, molecular pathways and metabolomics considerations. Life Sci. 2022;309: 121001. https:\/\/doi.org\/10.1016\/j.lfs.2022.121001.","journal-title":"Life Sci"},{"key":"3120_CR174","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2023.105832","volume":"110","author":"K Luk","year":"2023","unstructured":"Luk K, Chan C, Liu Z, Jiao C, Yang X, Dong X, et al. Selenium nanoparticles functionalized by mushroom polysaccharide-protein complex\u202f: A novel nano-mineral for managing postmenopausal osteoporosis. J Funct Foods. 2023;110: 105832. https:\/\/doi.org\/10.1016\/j.jff.2023.105832.","journal-title":"J Funct Foods"},{"key":"3120_CR175","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.colsurfb.2018.12.056","volume":"176","author":"S Wang","year":"2019","unstructured":"Wang S, Yang Y, Li Y, Shi J, Zhou J, Zhang L, et al. Strontium\/adiponectin co-decoration modulates the osteogenic activity of nano-morphologic polyetheretherketone implant. Colloids Surf B Biointerfaces. 2019;176:38\u201346. https:\/\/doi.org\/10.1016\/j.colsurfb.2018.12.056.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"3120_CR176","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.snb.2011.02.010","volume":"156","author":"H Suzuki","year":"2011","unstructured":"Suzuki H, Fukuda J. Sensors and Actuators B\u202f: Chemical Synergistic effects of micro \/ nano modifications on electrodes for microfluidic electrochemical ELISA. Sens Actuators B Chem. 2011;156:637\u201344. https:\/\/doi.org\/10.1016\/j.snb.2011.02.010.","journal-title":"Sens Actuators B Chem"},{"key":"3120_CR177","doi-asserted-by":"publisher","unstructured":"Chi M, Li N, Sharma N, Li W, Chen C, Dong B, et al. Positive regulation of osteogenesis on titanium surface by modification of nanosized Ca 2 + -exchanged EMT zeolites 2022;33. https:\/\/doi.org\/10.1016\/j.mtcomm.2022.104874.","DOI":"10.1016\/j.mtcomm.2022.104874"},{"key":"3120_CR178","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fbioe.2023.1205252","volume":"11","author":"C Qian","year":"2023","unstructured":"Qian C, Liu Y, Chen S, Zhang C, Chen X, Liu Y, et al. Electrospun core\u2013sheath PCL nanofibers loaded with nHA and simvastatin and their potential bone regeneration applications. Front Bioeng Biotechnol. 2023;11:1\u201311. https:\/\/doi.org\/10.3389\/fbioe.2023.1205252.","journal-title":"Front Bioeng Biotechnol"},{"key":"3120_CR179","doi-asserted-by":"publisher","first-page":"97613","DOI":"10.1039\/c6ra17141a","volume":"6","author":"N Ahmad","year":"2016","unstructured":"Ahmad N, Banala VT, Kushwaha P, Karvande A, Sharma S, Tripathi AK, et al. Quercetin-loaded solid lipid nanoparticles improve osteoprotective activity in an ovariectomized rat model: A preventive strategy for post-menopausal osteoporosis. RSC Adv. 2016;6:97613\u201328. https:\/\/doi.org\/10.1039\/c6ra17141a.","journal-title":"RSC Adv"},{"key":"3120_CR180","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1080\/10837450.2020.1765378","volume":"25","author":"S Gera","year":"2020","unstructured":"Gera S, Pooladanda V, Godugu C, Swamy Challa V, Wankar J, Dodoala S, et al. Rutin nanosuspension for potential management of osteoporosis: effect of particle size reduction on oral bioavailability, in vitro and in vivo activity. Pharm Dev Technol. 2020;25:971\u201388. https:\/\/doi.org\/10.1080\/10837450.2020.1765378.","journal-title":"Pharm Dev Technol"},{"key":"3120_CR181","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.2217\/nnm-2020-0079","volume":"15","author":"F Zakir","year":"2020","unstructured":"Zakir F, Ahmad A, Farooq U, Mirza MA, Tripathi A, Singh D, et al. Design and development of a commercially viable in situ nanoemulgel for the treatment of postmenopausal osteoporosis. Nanomedicine. 2020;15:1167\u201387. https:\/\/doi.org\/10.2217\/nnm-2020-0079.","journal-title":"Nanomedicine"},{"key":"3120_CR182","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1166\/jbn.2017.2372","volume":"13","author":"J Ahn","year":"2017","unstructured":"Ahn J, Jeong J, Lee H, Sung MJ, Jung CH, Lee H, et al. Poly(lactic-co-glycolic acid) nanoparticles potentiate the protective effect of curcumin against bone loss in ovariectomized rats. J Biomed Nanotechnol. 2017;13:688\u201398. https:\/\/doi.org\/10.1166\/jbn.2017.2372.","journal-title":"J Biomed Nanotechnol"},{"key":"3120_CR183","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpta.2024.100440","volume":"7","author":"S Pathak","year":"2024","unstructured":"Pathak S, Sahu P, Begum JPS, Kashaw SK, Pandey A, Semwal P, et al. Formulation and assessment of penetration potential of Risedronate chitosan nanoparticles loaded transdermal gel in the management of osteoporosis: In vitro and ex vivo screening. Carbohydr Polym Technol Appl. 2024;7: 100440. https:\/\/doi.org\/10.1016\/j.carpta.2024.100440.","journal-title":"Carbohydr Polym Technol Appl"},{"key":"3120_CR184","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.4155\/bio-2018-0136","volume":"10","author":"MR Yerrapragada","year":"2018","unstructured":"Yerrapragada MR, Unni HN. Paper-based microfluidic device for diagnosis of osteoporosis markers. Bioanalysis. 2018;10:1639\u201349. https:\/\/doi.org\/10.4155\/bio-2018-0136.","journal-title":"Bioanalysis"},{"key":"3120_CR185","doi-asserted-by":"publisher","first-page":"5219","DOI":"10.1021\/am4010495","volume":"5","author":"A Panahifar","year":"2013","unstructured":"Panahifar A, Mahmoudi M, Doschak MR. Synthesis and in vitro evaluation of bone-seeking superparamagnetic iron oxide nanoparticles as contrast agents for imaging bone metabolic activity. ACS Appl Mater Interfaces. 2013;5:5219\u201326. https:\/\/doi.org\/10.1021\/am4010495.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3120_CR186","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphys.2022.989487","volume":"13","author":"MM Elghareeb","year":"2022","unstructured":"Elghareeb MM, Elshopakey GE, Elkhooly TA, Salama B, Samy A, Bazer FW, et al. Estradiol and zinc-doped nano hydroxyapatite as therapeutic agents in the prevention of osteoporosis; oxidative stress status, inflammation, bone turnover, bone mineral density, and histological alterations in ovariectomized rats. Front Physiol. 2022;13:1\u201320. https:\/\/doi.org\/10.3389\/fphys.2022.989487.","journal-title":"Front Physiol"},{"key":"3120_CR187","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-019-01759-5","author":"XY Pan","year":"2019","unstructured":"Pan XY, Chen CH, Chang YH, Wang DY, Lee YC, Liou CC, et al. Osteoporosis risk assessment using multilayered gold-nanoparticle thin film via SALDI-MS measurement. Anal Bioanal Chem. 2019. https:\/\/doi.org\/10.1007\/s00216-019-01759-5.","journal-title":"Anal Bioanal Chem"},{"key":"3120_CR188","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1021\/acs.nanolett.1c04531","volume":"22","author":"Y Li","year":"2022","unstructured":"Li Y, Wen X, Deng Z, Jiang M, Zeng S. In vivo high-resolution bioimaging of bone marrow and fracture diagnosis using lanthanide nanoprobes with 1525 nm emission. Nano Lett. 2022;22:2691\u2013701. https:\/\/doi.org\/10.1021\/acs.nanolett.1c04531.","journal-title":"Nano Lett"},{"key":"3120_CR189","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.2c02900","author":"R Yan","year":"2022","unstructured":"Yan R, Guo Y, Wang X, Liang G, Yang A, Li J. Near-infrared light-controlled and real-time detection of osteogenic differentiation in mesenchymal stem cells by upconversion nanoparticles for osteoporosis therapy. ACS Nano. 2022. https:\/\/doi.org\/10.1021\/acsnano.2c02900.","journal-title":"ACS Nano"},{"key":"3120_CR190","doi-asserted-by":"publisher","unstructured":"Dias AM, do Nascimento Canhas I, Bruziquesi CGO, Speziali MG, Sinisterra RD, Cort\u00e9s ME. Magnesium (Mg2 +), Strontium (Sr2 +), and Zinc (Zn2 +) Co-substituted Bone Cements Based on Nano-hydroxyapatite\/Monetite for Bone Regeneration. Biol Trace Elem Res 2023;201:2963\u201381. https:\/\/doi.org\/10.1007\/s12011-022-03382-5.","DOI":"10.1007\/s12011-022-03382-5"},{"key":"3120_CR191","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1016\/j.actbio.2009.05.008","volume":"5","author":"KS Brammer","year":"2009","unstructured":"Brammer KS, Oh S, Cobb CJ, Bjursten LM, van der Heyde H, Jin S. Improved bone-forming functionality on diameter-controlled TiO2 nanotube surface. Acta Biomater. 2009;5:3215\u201323. https:\/\/doi.org\/10.1016\/j.actbio.2009.05.008.","journal-title":"Acta Biomater"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03120-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-025-03120-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03120-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T16:46:50Z","timestamp":1751906810000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-025-03120-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":191,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["3120"],"URL":"https:\/\/doi.org\/10.1208\/s12249-025-03120-9","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,9]]},"assertion":[{"value":"11 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research Involving Human and Animal"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"129"}}